当前位置: X-MOL 学术Lancet › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Induced hypothermia in patients with septic shock and respiratory failure (CASS): a randomised, controlled, open-label trial.
The Lancet ( IF 98.4 ) Pub Date : 2018-03-01 , DOI: 10.1016/s2213-2600(18)30004-3
Theis Skovsgaard Itenov 1 , Maria Egede Johansen 2 , Morten Bestle 3 , Katrin Thormar 4 , Lars Hein 3 , Louise Gyldensted 5 , Anne Lindhardt 4 , Henrik Christensen 6 , Stine Estrup 7 , Henrik Planck Pedersen 8 , Matthew Harmon 9 , Uday Kant Soni 10 , Silvia Perez-Protto 11 , Nicolai Wesche 3 , Ulrik Skram 3 , John Asger Petersen 4 , Thomas Mohr 5 , Tina Waldau 6 , Lone Musaeus Poulsen 7 , Ditte Strange 4 , Nicole P Juffermans 9 , Daniel I Sessler 12 , Else Tønnesen 13 , Kirsten Møller 14 , Dennis Karsten Kristensen 2 , Alessandro Cozzi-Lepri 15 , Jens D Lundgren 2 , Jens-Ulrik Jensen 16 ,
Affiliation  

Animal models of serious infection suggest that 24 h of induced hypothermia improves circulatory and respiratory function and reduces mortality. We tested the hypothesis that a reduction of core temperature to 32-34°C attenuates organ dysfunction and reduces mortality in ventilator-dependent patients with septic shock.

中文翻译:


败血性休克和呼吸衰竭(CASS)患者的诱导低温:一项随机、对照、开放标签试验。



严重感染的动物模型表明,24 小时诱导低温可改善循环和呼吸功能并降低死亡率。我们测试了以下假设:将核心温度降低至 32-34°C 可减轻器官功能障碍并降低依赖呼吸机的感染性休克患者的死亡率。
更新日期:2018-02-27
down
wechat
bug